Skip to main content

Jonathan L. Kravetz

Member Emeritus

Share:

Jon retired from Mintz in 2024. He was Chair of the Securities & Capital Markets Practice Group and Co-chair of the Life Sciences Practice Group.

viewpoints

Caremark Liability Following the SEC’s New ESG Reporting Requirements

December 16, 2022 | Blog | By Jacob Hupart, Doug Baumstein, Jonathan L. Kravetz , Ellen Shapiro, Will G. McKitterick

Read more
Read about how institutional investors, proxy advisors, society, and asset managers are using their voting power to influence companies to adopt Environmental, Social and Governance (ESG) governance factors and goals.
Read more

Environmental Disclosures: Considerations for Board Members

September 17, 2021 | Blog | By Jacob Hupart, Megan Gates, Jonathan L. Kravetz , Doug Baumstein

Read more

Life Sciences Newsletter — September 2021

September 1, 2021 | Article | By Adam Lenain, William Whelan, Jonathan L. Kravetz , Terri Shieh-Newton

This edition covers return-to-work challenges, insight on patenting AI innovations, FDA guidance on medical devices, transactional and IP activity in the life sciences, and recent Mintz work for life sciences clients.
Read more

Life Sciences Newsletter — Inaugural Edition

August 20, 2020 | Article | By Adam Lenain, William Whelan, Jonathan L. Kravetz , Terri Shieh-Newton

The inaugural Mintz Life Sciences Newsletter brings the latest developments in life sciences, legal insights, and industry activity straight to your inbox.
Read more
Read less

News & Press

Read less

Jonathan L. Kravetz

Member Emeritus